ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 58573 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 58573; 2) Community: the network communities that were significantly associated with the response to NSC 58573; 3) Molecule: the relationships between components within communities and NSC 58573; 4) MDR: the compounds that were significantly associated with the NSC 58573.

NSC Compound Enrichment Correlation
NSC 7821 [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride 0.0137891122538509 0.18932843
NSC 100880 Camptothecin 0.013789112253851 0.011266638
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.013789112253851 0.03472371
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.013789112253851 0.15936838
NSC 18805 .gamma.-Thujaplicine 0.013789112253851 0.34202006
NSC 244404 Null 0.013789112253851 0.39072664
NSC 30915 Null 0.013789112253851 0.55935451
NSC 328410 Camptothecin Derivative 0.013789112253851 -0.011036091
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.013789112253851 0.37811199
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.013789112253851 0.55130007
Total:125  Current:59    [First] [Prev] [Next] [Last]